PK Blood Collection: Dose 1 – Even Dataset in Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections

Timing of pharmacokinetic samples in participants born on an even numbered day
Study Description
An open-label, multiple-dose study to determine the safety, tolerability, and pharmacokinetics of meropenem in preterm and term infants less than 91 days of age with suspected or confirmed intra-abdominal infections. Biospecimens are available.
Infants less than 91 days of age with suspected or confirmed intra-abdominal infection

出生日期为偶数日的受试者的药代动力学（pharmacokinetics）样本采集时序
研究概况
本研究为一项开放标签多剂量临床试验，旨在评估年龄小于91日的疑似或确诊腹腔内感染早产儿及足月儿使用美罗培南（meropenem）的安全性、耐受性及药代动力学特征。可提供生物标本。
年龄小于91日的疑似或确诊腹腔内感染婴儿